Unknown

Dataset Information

0

Treatment of Hepatocellular Carcinoma With Lenvatinib.

ABSTRACT:

SUBMITTER: Han KH 

PROVIDER: S-EPMC6284340 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Treatment of Hepatocellular Carcinoma With Lenvatinib.

Han Kwang-Hyub KH  

Gastroenterology & hepatology 20181101 11

Similar Datasets

Unknown Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date.
| S-EPMC6362912 | biostudies-literature
Unknown Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.
| S-EPMC7024896 | biostudies-literature
Unknown FDA Supplemental Approval Summary: Lenvatinib for the Treatment of Unresectable Hepatocellular Carcinoma.
| S-EPMC7930400 | biostudies-literature
Unknown Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma.
| S-EPMC7768146 | biostudies-literature
Unknown Lenvatinib continuation versus regorafenib in treating hepatocellular carcinoma after lenvatinib failure.
| S-EPMC12780716 | biostudies-literature
Unknown Ultrasound-triggered nano delivery of lenvatinib for selective immunotherapy treatment against hepatocellular carcinoma.
| S-EPMC11550808 | biostudies-literature
Unknown Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment.
| S-EPMC7225985 | biostudies-literature
Unknown Lenvatinib for Hepatocellular Carcinoma: A Literature Review.
| S-EPMC7825021 | biostudies-literature
Unknown Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.
| S-EPMC8907842 | biostudies-literature
Unknown Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma.
| S-EPMC9909711 | biostudies-literature